Protein Crystallization Market Report 2026

The protein crystallization market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to expansion of structural biology research, rising demand for protein structure determination, growth in pharmaceutical drug discovery programs, increased use of x-ray crystallography, availability of advanced laboratory instrumentation.

The protein crystallization market size is expected to see rapid growth in the next few years. It will grow to $3.08 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing adoption of cryo-electron microscopy workflows, rising investment in protein structure-based drug design, expansion of AI-assisted crystallography, growing focus on complex protein analysis, increasing collaboration between academia and industry. Major trends in the forecast period include increasing use of automated crystallization systems, rising adoption of microfluidic crystallization techniques, growing integration of AI-based structure prediction tools, expansion of high-resolution structural analysis, enhanced focus on reproducible crystal formation.

The increasing demand for biopharmaceuticals is expected to drive the growth of the protein crystallization market in the coming years. Biopharmaceuticals are medicinal products developed using biological sources or techniques, including proteins, vaccines, and gene therapies, to treat a variety of diseases and medical conditions. The growing demand for biopharmaceuticals is driven by their ability to deliver targeted therapies, improve patient outcomes, and address numerous chronic and complex diseases by offering personalized and more effective alternatives to conventional treatments. Protein crystallization supports biopharmaceutical development by allowing accurate determination of protein structures, which helps advance targeted therapies and improves the efficacy and stability of biopharmaceutical products. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the United States had 33 biosimilar products approved by the FDA, with 21 available on the market. By 2023, the number of FDA-approved biosimilars increased to 40, with 25 commercially available. Therefore, the growing demand for biopharmaceuticals is contributing to the expansion of the protein crystallization market.

Major companies operating in the protein crystallization market are concentrating on the development of advanced solutions such as microfluidic platforms to improve crystal quality and increase throughput. Microfluidic platforms are specialized systems that provide precise control over protein crystallization using small volumes and carefully regulated conditions, increasing the chances of producing high-quality crystals suitable for X-ray crystallography. For example, in April 2024, a US-based research team from Arizona State University successfully launched microfluidic protein crystallization devices into space aboard SpaceX’s Cargo Dragon Capsule, where they were designed to function under microgravity conditions. This platform allows multiple proteins to be screened simultaneously and supports high-throughput crystallization experiments. Growing crystals in reduced gravitational environments improves structural quality and enables the crystallization of proteins that are difficult to crystallize on Earth. The devices are compatible with X-ray diffraction analysis, enabling researchers to directly obtain three-dimensional protein structures from the crystallization hardware.

In October 2025, Pharmaron Beijing Co. Ltd., a China-based provider of integrated pharmaceutical research and development services, acquired Biortus Biosciences Co. Ltd. for an undisclosed amount. Through this acquisition, Pharmaron aims to strengthen its structure-based drug discovery and protein science capabilities, particularly in areas such as complex protein production, X-ray crystallography, cryo-electron microscopy, and AI and machine learning-driven structural analysis. Biortus Biosciences Co. Ltd. is a China-based contract research organization specializing in structural biology, offering comprehensive services ranging from gene to protein to three-dimensional structure, and utilizing a proprietary AI and machine learning computational platform for protein complex design and validation.

Major companies operating in the protein crystallization market are Thermo Fisher Scientific, Corning Incorporated, Charles River Laboratories, Mettler-Toledo International Inc., Douglas Instruments Limited, Bruker Corporation, Tecan Group, Greiner Bio-One International GmbH, Rigaku Corporation, Viva Biotech, Formulatrix Inc., Creative Biostructure, Calibre Scientific Inc., Creative Biolabs, Molecular Dimensions, Creative Proteomics, Jena Bioscience GmbH, Saromics Biostructures, Art Robbins Instruments, Mitegen.

North America was the largest region in the protein crystallization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein crystallization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein crystallization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the protein crystallization market by increasing costs of imported crystallization instruments, x-ray diffractometers, microfluidic devices, imaging systems, and specialized consumables. Pharmaceutical and academic research centers in North America and Europe are most affected due to reliance on high-end imported equipment, while Asia-Pacific faces higher export-related cost pressures. These tariffs are raising capital investment requirements and extending equipment upgrade cycles. However, they are also supporting domestic instrument manufacturing, regional supplier development, and localized service offerings for crystallography solutions.

The protein crystallization market research report is one of a series of new reports that provides protein crystallization market statistics, including protein crystallization industry global market size, regional shares, competitors with a protein crystallization market share, detailed protein crystallization market segments, market trends and opportunities, and any further data you may need to thrive in the protein crystallization industry. This protein crystallization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein crystallization is the process by which proteins are encouraged to form highly ordered, three-dimensional crystals under controlled conditions, typically by adjusting factors such as temperature, pH levels, and the presence of specific solvents or salts. This technique is essential in structural biology, as it allows scientists to examine the atomic-level structure of proteins in detail, most commonly using methods such as X-ray diffraction, which helps reveal protein functions and interactions.

The primary product types in the protein crystallization market include instruments, consumables, software, and services. Instruments refer to the tools and equipment used in scientific research to support the measurement, analysis, and handling of materials, particularly for determining protein structures. The key technologies involved include X-ray crystallography, cryo-electron microscopy, NMR spectroscopy, and others. These solutions are utilized by end users such as pharmaceutical and biotechnology companies, as well as academic and research institutes.

The protein crystallization market consists of revenues earned by entities by providing services such as custom crystallization assay development, cryogenic storage of protein crystals, x-ray diffraction data collection, automated crystallization platforms, and microgravity crystallization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein crystallization market includes sales of protein crystallization screening kits, crystallization optimization reagents, crystallization equipment, cryo-electron microscopy (cryo-EM) systems for protein analysis, and crystallization software licenses. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.